Cargando…
Pilot Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Feasibility of an Intranasal Oxytocin in Improving Social Cognition in Individuals Living with Alzheimer’s Disease
BACKGROUND: Individuals living with Alzheimer’s disease (AD) demonstrate extensive deficits in social cognition. To date, no studies have investigated the feasibility of an intranasal oxytocin (INOT) treatment to improve social cognition in individuals living with AD. OBJECTIVE: We conducted a pilot...
Autores principales: | Michaelian, Johannes C., McCade, Donna, Hoyos, Camilla M., Brodaty, Henry, Harrison, Fleur, Henry, Julie D., Guastella, Adam J., Naismith, Sharon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357119/ https://www.ncbi.nlm.nih.gov/pubmed/37483320 http://dx.doi.org/10.3233/ADR-230013 |
Ejemplares similares
-
The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism: a single-blind, randomized, placebo-controlled, crossover design study
por: Lin, I-Fan, et al.
Publicado: (2014) -
The effect of intranasal oxytocin on the perception of affective touch and multisensory integration in anorexia nervosa: protocol for a double-blind placebo-controlled crossover study
por: Crucianelli, Laura, et al.
Publicado: (2019) -
Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial
por: Quintana, D S, et al.
Publicado: (2017) -
Evaluating the efficacy of intranasal oxytocin on pain and function among individuals who experience chronic pain: a protocol for a multisite, placebo-controlled, blinded, sequential, within-subjects crossover trial
por: Rash, Joshua A., et al.
Publicado: (2021) -
Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin
por: Damen, Layla, et al.
Publicado: (2020)